[
  {
    "ts": "2026-02-09T03:50:00+00:00",
    "headline": "2 Warren Buffett Stocks to Buy Hand Over Fist in 2026 and 1 to Avoid",
    "summary": "Two top Berkshire Hathaway holdings have strong comeback potential, but another one should be avoided for now.",
    "url": "https://www.fool.com/investing/2026/02/08/2-warren-buffett-stocks-to-buy-hand-over-fist-in-2/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "c9c5bac2-2170-3813-9b12-69ca4692e24f",
      "content": {
        "id": "c9c5bac2-2170-3813-9b12-69ca4692e24f",
        "contentType": "STORY",
        "title": "2 Warren Buffett Stocks to Buy Hand Over Fist in 2026 and 1 to Avoid",
        "description": "",
        "summary": "Two top Berkshire Hathaway holdings have strong comeback potential, but another one should be avoided for now.",
        "pubDate": "2026-02-09T03:50:00Z",
        "displayTime": "2026-02-09T03:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/275376608f1cb11a09c81a3f1c363704",
          "originalWidth": 1188,
          "originalHeight": 788,
          "caption": "Warren Buffett smiling",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/v1ujUvQ39IOI..4VUV9yDQ--~B/aD03ODg7dz0xMTg4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/275376608f1cb11a09c81a3f1c363704.cf.webp",
              "width": 1188,
              "height": 788,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.2JddBjOvH_smzv06KuMlg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/275376608f1cb11a09c81a3f1c363704.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/08/2-warren-buffett-stocks-to-buy-hand-over-fist-in-2/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-warren-buffett-stocks-buy-035000223.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BRK.A"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "DVA"
            },
            {
              "symbol": "KHC"
            },
            {
              "symbol": "INTC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T05:31:11+00:00",
    "headline": "The 5 Most Interesting Analyst Questions From DaVita’s Q4 Earnings Call",
    "summary": "DaVita’s fourth quarter results drew a positive market response, as the company outpaced Wall Street expectations on both revenue and non-GAAP profit. Management identified revenue per treatment growth and disciplined execution in its Integrated Kidney Care (IKC) segment as the main contributors to performance, despite a year-over-year decline in operating margin. CEO Javier Rodriguez highlighted the company’s progress in patient outcomes within IKC programs, citing better treatment adherence an",
    "url": "https://finance.yahoo.com/news/5-most-interesting-analyst-questions-053111804.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "098e1562-3bd6-339f-8ca4-53f43324a7b3",
      "content": {
        "id": "098e1562-3bd6-339f-8ca4-53f43324a7b3",
        "contentType": "STORY",
        "title": "The 5 Most Interesting Analyst Questions From DaVita’s Q4 Earnings Call",
        "description": "",
        "summary": "DaVita’s fourth quarter results drew a positive market response, as the company outpaced Wall Street expectations on both revenue and non-GAAP profit. Management identified revenue per treatment growth and disciplined execution in its Integrated Kidney Care (IKC) segment as the main contributors to performance, despite a year-over-year decline in operating margin. CEO Javier Rodriguez highlighted the company’s progress in patient outcomes within IKC programs, citing better treatment adherence an",
        "pubDate": "2026-02-09T05:31:11Z",
        "displayTime": "2026-02-09T05:31:11Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/1c7567012554a1dbc086729cde9f4795",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "DVA Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4TnYLyTdXGGvoFRhuJkfKA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/1c7567012554a1dbc086729cde9f4795.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nuxyJbIzKFcPZE47ankl8g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/1c7567012554a1dbc086729cde9f4795.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/5-most-interesting-analyst-questions-053111804.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/5-most-interesting-analyst-questions-053111804.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DVA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]